Reneo Pharmaceuticals, Inc. (RPHM)

NASDAQ: RPHM · IEX Real-Time Price · USD
5.58
+0.16 (2.95%)
Mar 29, 2023, 4:30 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Selling, General & Admin
16.1411.653.612.38
Research & Development
37.7128.1715.9413.1
Operating Expenses
53.8539.8219.5515.47
Operating Income
-53.85-39.82-19.55-15.47
Other Expense / Income
-1.89-0.05-0.09-3.04
Pretax Income
-51.96-39.77-19.47-12.44
Net Income
-51.96-39.77-19.47-12.44
Shares Outstanding (Basic)
241822
Shares Outstanding (Diluted)
241822
Shares Change
35.01%794.56%4.11%-
EPS (Basic)
-2.12-2.19-9.60-6.38
EPS (Diluted)
-2.12-2.19-9.60-6.38
Free Cash Flow Per Share
-1.95-2.10-9.15-6.42
EBITDA
-51.43-39.72-19.43-12.4
Depreciation & Amortization
0.530.050.040.03
EBIT
-51.96-39.77-19.47-12.44
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).